Supernus Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.

CEO

Jack A. Khattar

CEOJack A. Khattar

Employees

674

Employees674

Headquarters

Rockville, Maryland

HeadquartersRockville, Maryland

Founded

2005

Founded2005

Employees

674

Employees674

SUPN Key Statistics

Market cap

1.80B

Market cap1.80B

Price-Earnings ratio

24.41

Price-Earnings ratio24.41

Dividend yield

—

Dividend yield—

Average volume

409.09K

Average volume409.09K

High today

$32.36

High today$32.36

Low today

$31.17

Low today$31.17

Open price

$31.41

Open price$31.41

Volume

352.97K

Volume352.97K

52 Week high

$40.28

52 Week high$40.28

52 Week low

$25.53

52 Week low$25.53

Supernus Pharmaceuticals

Why Robinhood?

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. Show more

SUPN Key Statistics

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.